Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 21, 2023
Total Value: $286M (95.0% shares, 5.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS INC | 92,500 | $21.37M | 7.5% | $127.76 | +112.0% | COM | 558868105 |
| — | CEREVEL THERAPEUTICS HLDNG I | 550,000 | $17.48M | 6.1% | $29.47 | — | COM | 15678U128 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 211,608 | $14.52M | 5.1% | $66.21 | +4.3% | COM | G31249108 |
| — | CHINOOK THERAPEUTICS INC | 321,017 | $12.33M | 4.3% | $17.48 | — | COM | 16961L106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 53,100 | $12.27M | 4.3% | $127.76 | +112.0% | Call | 558868105 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,600,000 | $12.05M | 4.2% | $7.53 | — | SPONSORED ADS | 881624209 |
| — | MORPHIC HLDG INC | 201,887 | $11.57M | 4.0% | $45.01 | — | COM | 61775R105 |
| — | CYMABAY THERAPEUTICS INC | 1,050,118 | $11.5M | 4.0% | $3.32 | — | COM | 23257D103 |
| BIIB | BIOGEN INC | 40,000 | $11.39M | 4.0% | $297.86 | 0.0% | COM | 09062X103 |
| KURA | KURA ONCOLOGY INC | 910,317 | $9.631M | 3.4% | $15.32 | -22.8% | COM | 50127T109 |
| — | VERONA PHARMA PLC | 447,667 | $9.464M | 3.3% | $13.28 | — | SPONSORED ADS | 925050106 |
| — | BRIDGEBIO PHARMA INC | 12,000,000 | $9.453M | 3.3% | $0.75 | — | NOTE 2.500% 3/1 | 10806XAB8 |
| ACLX | ARCELLX INC | 226,275 | $7.155M | 2.5% | $19.79 | +93.1% | COMMON STOCK | 03940C100 |
| PRTA | PROTHENA CORP PLC | 100,000 | $6.828M | 2.4% | $64.50 | 0.0% | SHS | G72800108 |
| BBIO | BRIDGEBIO PHARMA INC | 376,000 | $6.467M | 2.3% | $11.66 | +29.0% | Put | 10806X102 |
| VKTX | VIKING THERAPEUTICS INC | 350,000 | $5.673M | 2.0% | $6.55 | +219.7% | Put | 92686J106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 900,723 | $5.575M | 1.9% | $4.28 | — | SPONSORED ADS | 152309100 |
| — | ASTRIA THERAPEUTICS INC | 650,875 | $5.422M | 1.9% | $9.93 | — | COM | 04635X102 |
| ASND | ASCENDIS PHARMA A/S | 57,760 | $5.155M | 1.8% | $108.03 | — | SPONSORED ADR | 04351P101 |
| IMVT | IMMUNOVANT INC | 260,000 | $4.932M | 1.7% | $18.65 | 0.0% | COM | 45258J102 |
| VKTX | VIKING THERAPEUTICS INC | 300,000 | $4.863M | 1.7% | $6.55 | +219.7% | COM | 92686J106 |
| AZN | ASTRAZENECA PLC | 60,000 | $4.294M | 1.5% | $61.36 | — | SPONSORED ADR | 046353108 |
| — | INOZYME PHARMA INC | 751,796 | $4.188M | 1.5% | $2.62 | — | COM | 45790W108 |
| CYTK | CYTOKINETICS INC | 125,148 | $4.082M | 1.4% | $42.64 | -13.2% | COM NEW | 23282W605 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 1,589,017 | $3.782M | 1.3% | $2.38 | — | SPON ADS | 05280R100 |
| IMTX | IMMATICS N.V | 300,000 | $3.462M | 1.2% | $9.33 | 0.0% | SHS | N44445109 |
| — | ESPERION THERAPEUTICS INC NE | 6,925,000 | $3.441M | 1.2% | $0.45 | — | NOTE 4.000%11/1 | 29664WAB1 |
| — | SPRINGWORKS THERAPEUTICS INC | 130,000 | $3.409M | 1.2% | $26.22 | — | COM | 85205L107 |
| VTYX | VENTYX BIOSCIENCES INC | 100,696 | $3.303M | 1.2% | $25.42 | +35.6% | COM | 92332V107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 130,400 | $3.102M | 1.1% | — | — | Call | 92790C104 |
| — | REATA PHARMACEUTICALS INC | 29,105 | $2.968M | 1.0% | $101.96 | — | CL A | 75615P103 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 87,031 | $2.953M | 1.0% | $33.38 | +1.0% | COM NEW | 15117B202 |
| — | FIBROGEN INC | 983,300 | $2.655M | 0.9% | $2.70 | — | COM | 31572Q808 |
| — | FIBROGEN INC | 983,300 | $2.655M | 0.9% | $2.70 | — | Put | 31572Q808 |
| XENE | XENON PHARMACEUTICALS INC | 60,376 | $2.324M | 0.8% | $36.65 | +8.5% | COM | 98420N105 |
| — | THESEUS PHARMACEUTICALS INC | 240,244 | $2.241M | 0.8% | $9.15 | — | COM | 88369M101 |
| — | AEGLEA BIOTHERAPEUTICS INC | 4,900,000 | $2.207M | 0.8% | $0.45 | — | COM | 00773J103 |
| — | VINCERX PHARMA INC | 1,492,771 | $1.941M | 0.7% | $13.47 | — | COM NEW | 92731L106 |
| LIANY | LIANBIO | 800,676 | $1.826M | 0.6% | $2.95 | — | SPONSORED ADS | 53000N108 |
| CABA | CABALETTA BIO INC | 125,000 | $1.614M | 0.6% | $10.85 | 0.0% | COM | 12674W109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 178,292 | $1.605M | 0.6% | $9.54 | -3.4% | COM | 483497103 |
| — | PRECIGEN INC | 1,500,000 | $1.507M | 0.5% | $0.97 | — | NOTE 3.500% 7/0 | 46122TAA0 |
| ADCT | ADC THERAPEUTICS SA | 600,000 | $1.29M | 0.5% | $3.69 | -39.1% | SHS | H0036K147 |
| WHWK | AADI BIOSCIENCE INC | 187,675 | $1.284M | 0.4% | $7.77 | 0.0% | COM | 00032Q104 |
| ALDX | ALDEYRA THERAPEUTICS INC | 150,000 | $1.258M | 0.4% | $9.85 | 0.0% | COM | 01438T106 |
| — | ALPINE IMMUNE SCIENCES INC | 118,891 | $1.222M | 0.4% | $7.28 | — | COM | 02083G100 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 100,000 | $1.189M | 0.4% | $13.27 | 0.0% | ORDINARY SHARES | N62509109 |
| — | ARAVIVE INC | 861,200 | $1.085M | 0.4% | — | — | Put | 03890D108 |
| IFRX | INFLARX NV | 240,200 | $1.071M | 0.4% | $4.48 | 0.0% | COM | N44821101 |
| MLYS | MINERALYS THERAPEUTICS INC | 62,500 | $1.066M | 0.4% | $16.83 | -11.2% | COM | 603170101 |
| NRIX | NURIX THERAPEUTICS INC | 100,000 | $999K | 0.3% | $11.30 | -9.7% | COM | 67080M103 |
| BCAB | BIOATLA INC | 325,000 | $975K | 0.3% | $5.77 | -40.4% | COM | 09077B104 |
| — | FIBROGEN INC | 340,000 | $918K | 0.3% | $2.70 | — | Call | 31572Q808 |
| APLS | APELLIS PHARMACEUTICALS INC | 10,000 | $911K | 0.3% | $57.70 | +49.5% | COM | 03753U106 |
| AXSM | AXSOME THERAPEUTICS INC | 12,500 | $898K | 0.3% | $73.77 | 0.0% | COM | 05464T104 |
| MIST | MILESTONE PHARMACEUTICALS IN | 300,068 | $855K | 0.3% | $4.23 | -10.9% | COM | 59935V107 |
| MIRM | MIRUM PHARMACEUTICALS INC | 30,000 | $776K | 0.3% | $21.52 | +23.6% | COM | 604749101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 202,349 | $714K | 0.2% | $3.69 | -15.4% | COM | 74587V107 |
| PCVX | VAXCYTE INC | 13,923 | $695K | 0.2% | $39.36 | +20.4% | COM | 92243G108 |
| — | JASPER THERAPEUTICS INC | 476,948 | $653K | 0.2% | $1.81 | — | COM | 471871103 |
| — | IMMATICS N.V | 187,204 | $633K | 0.2% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| — | TALARIS THERAPEUTICS INC | 200,000 | $608K | 0.2% | $3.04 | — | COM | 87410C104 |
| BBIO | BRIDGEBIO PHARMA INC | 35,133 | $604K | 0.2% | $11.66 | +29.0% | COM | 10806X102 |
| VIR | VIR BIOTECHNOLOGY INC | 20,000 | $491K | 0.2% | $25.11 | 0.0% | COM | 92764N102 |
| NUVB | NUVATION BIO INC | 250,000 | $450K | 0.2% | $2.02 | -16.0% | COM CL A | 67080N101 |
| — | NLS PHARMACEUTICS LTD | 400,000 | $440K | 0.2% | $1.45 | — | SHS | H57830103 |
| CNTX | CONTEXT THERAPEUTICS INC | 267,574 | $428K | 0.1% | $0.85 | 0.0% | COM | 21077P108 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 37,000 | $77,330 | 0.0% | $1.85 | — | *W EXP 11/22/202 | N62509117 |
| — | ARAVIVE INC | 33,600 | $42,336 | 0.0% | — | — | Call | 03890D108 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 75,000 | $13,913 | 0.0% | $0.16 | — | *W EXP 09/02/202 | 77313F114 |